retatrutide microdose Retatrutide—A Game Changer in Obesity Pharmacotherapy Is a new weight-loss drug

Frias JP, Bonora E, Ruiz LN et al (2021) Efficacy and safety of dulaglutide 3.0 mg and 4.5 mg versus dulaglutide 1.5 mg in metformin-treated patients with type 2 diabetes in a randomized controlled trial (AWARD-11)

Trusted expertise Over 110,000+ prescriptions filled with personalized dosing from licensed healthcare providers

Participants in the phase 2 trial lost an average of 7 kg (15 lbs) after 16 weeks, significantly more than the placebo group

Some people also believe the drug has a future as anti-addiction medication thanks to reports that semaglutide suppresses the desire to do activities like drink alcohol and go shopping

Its a conversation that should be held between each patient and their practitioner to weigh the risks of continuing with the medication versus the risks of stopping, Dr

Takeaway: Shed provides telehealth-based access to GLP-1 prescriptions with home delivery, with follow-up care that may vary by program structure